5 results match your criteria: "Max Planck Institute of PsychiatryMunich[Affiliation]"

Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response.

Front Mol Neurosci

August 2017

Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, University of CampinasCampinas, Brazil.

The current inability of clinical psychiatry to objectively select the most appropriate treatment is a major factor contributing to the severity and clinical burden of major depressive disorder (MDD). Here, we have attempted to identify plasma protein signatures in 39 MDD patients to predict response over a 6-week treatment period with antidepressants. LC-MS/MS analysis showed that differences in the levels of 29 proteins at baseline were found in the group with a favorable treatment outcome.

View Article and Find Full Text PDF

Late-Onset Cognitive Impairments after Early-Life Stress Are Shaped by Inherited Differences in Stress Reactivity.

Front Cell Neurosci

February 2017

Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of PsychiatryMunich, Germany; Department of Behavioural Biology, University of OsnabrückOsnabrück, Germany.

Early-life stress (ELS) has been associated with lasting cognitive impairments and with an increased risk for affective disorders. A dysregulation of the hypothalamus-pituitary-adrenal (HPA) axis, the body's main stress response system, is critically involved in mediating these long-term consequences of adverse early-life experience. It remains unclear to what extent an inherited predisposition for HPA axis sensitivity or resilience influences the relationship between ELS and cognitive impairments, and which neuroendocrine and molecular mechanisms may be involved.

View Article and Find Full Text PDF

Stuck between Bench and Bedside: Why Non-invasive Brain Stimulation Is Not Accessible to Depressed Patients in Europe.

Front Hum Neurosci

February 2017

Department of Psychology, Institute of Behavioral Sciences, University of HelsinkiHelsinki, Finland; Department of Psychiatry, Institute of Clinical Medicine, University of Eastern FinlandKuopio, Finland; Department of Psychiatry, Kuopio University HospitalKuopio, Finland.

View Article and Find Full Text PDF

[This corrects the article on p. 108 in vol. 10, PMID: 27199662.

View Article and Find Full Text PDF

The neurophysiological processes that can cause theta-to-gamma frequency range (4-80 Hz) network oscillations in the rhinal cortical-hippocampal system and the potential connectivity-based interactions of such forebrain rhythms are a topic of intensive investigation. Here, using selective Channelrhodopsin-2 (ChR2) expression in mouse forebrain glutamatergic cells, we were able to locally, temporally precisely, and reliably induce fast (20-40 Hz) field potential oscillations in hippocampal area CA1 in vitro (at 25°C) and in vivo (i.e.

View Article and Find Full Text PDF